
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy... Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.37 | -2.32558139535 | 15.91 | 16.43 | 15.53 | 269446 | 16.17420536 | CS |
4 | -0.58 | -3.59801488834 | 16.12 | 16.97 | 14.98 | 357869 | 16.00212416 | CS |
12 | 4.265 | 37.8270509978 | 11.275 | 16.97 | 10.75 | 386812 | 13.63574278 | CS |
26 | 7.54 | 94.25 | 8 | 16.97 | 7.784 | 373007 | 11.61167121 | CS |
52 | 11.14 | 253.181818182 | 4.4 | 16.97 | 3.7 | 310233 | 9.55039554 | CS |
156 | 9.08 | 140.557275542 | 6.46 | 16.97 | 2.25 | 349062 | 6.41400277 | CS |
260 | 15.4401 | 15455.5555556 | 0.0999 | 25.18 | 0.0999 | 252916 | 7.34178975 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관